Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes

Background— - - We aimed to describe the effects of ticagrelor versus clopidogrel on stent thrombosis in the Platelet Inhibition and Patient Outcomes (PLATO) trial. - - Methods and Results— - - Of 18 624 patients hospitalized for acute coronary syndromes, 11 289 (61%) had at least 1 intracoronary...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Steg, P. Gabriel (VerfasserIn) , Harrington, Robert A. (VerfasserIn) , Emanuelsson, Håkan (VerfasserIn) , Katus, Hugo (VerfasserIn) , Mahaffey, Kenneth W. (VerfasserIn) , Meier, Bernhard (VerfasserIn) , Storey, Robert F. (VerfasserIn) , Wojdyla, Daniel M. (VerfasserIn) , Lewis, Basil S. (VerfasserIn) , Maurer, Gerald (VerfasserIn) , Wallentin, Lars (VerfasserIn) , James, Stefan K. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2013
In: Circulation
Year: 2013, Jahrgang: 128, Heft: 10, Pages: 1055-1065
ISSN:1524-4539
DOI:10.1161/CIRCULATIONAHA.113.002589
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/CIRCULATIONAHA.113.002589
Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.113.002589
Volltext
Verfasserangaben:P. Gabriel Steg, Robert A. Harrington, Håkan Emanuelsson, Hugo A. Katus, Kenneth W. Mahaffey, Bernhard Meier, Robert F. Storey, Daniel M. Wojdyla, Basil S. Lewis, Gerald Maurer, Lars Wallentin, Stefan K. James for the PLATO Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 1789622859
003 DE-627
005 20230426075810.0
007 cr uuu---uuuuu
008 220215s2013 xx |||||o 00| ||eng c
024 7 |a 10.1161/CIRCULATIONAHA.113.002589  |2 doi 
035 |a (DE-627)1789622859 
035 |a (DE-599)KXP1789622859 
035 |a (OCoLC)1341441778 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Steg, P. Gabriel  |e VerfasserIn  |0 (DE-588)1110230362  |0 (DE-627)864831927  |0 (DE-576)475757866  |4 aut 
245 1 0 |a Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes  |c P. Gabriel Steg, Robert A. Harrington, Håkan Emanuelsson, Hugo A. Katus, Kenneth W. Mahaffey, Bernhard Meier, Robert F. Storey, Daniel M. Wojdyla, Basil S. Lewis, Gerald Maurer, Lars Wallentin, Stefan K. James for the PLATO Study Group 
264 1 |c 2013 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.02.2022 
520 |a Background— - - We aimed to describe the effects of ticagrelor versus clopidogrel on stent thrombosis in the Platelet Inhibition and Patient Outcomes (PLATO) trial. - - Methods and Results— - - Of 18 624 patients hospitalized for acute coronary syndromes, 11 289 (61%) had at least 1 intracoronary stent. Ticagrelor reduced stent thrombosis compared with clopidogrel across all definitions: definite, 1.37% (n=71) versus 1.93% (n=105; hazard ratio [HR], 0.67; 95% confidence interval [CI], 0.50-0.90; P=0.0091); definite or probable, 2.21% (n=118) versus 2.87% (n=157; HR, 0.75; 95% CI, 0.59-0.95; P=0.017); and definite, probable, and possible, 2.94% (n=154) versus 3.77 (n=201; HR, 0.77; 95% CI, 0.62-0.95). The reduction in definite stent thrombosis was consistent regardless of acute coronary syndrome type, presence of diabetes mellitus, stent type (drug-eluting or bare metal stent), CYP2C19 genetic status, loading dose of aspirin, dose of clopidogrel before randomization, and use of glycoprotein IIb/IIIa inhibitors at randomization. The reduction in stent thrombosis with ticagrelor was numerically greater for late (>30 days; HR, 0.48; 95% CI, 0.24-0.96) and subacute (4 hours-30 days; HR, 0.60; 95% CI, 0.39-0.93) compared with acute (<24 hours; HR, 0.94; 95% CI, 0.43-2.05) stent thrombosis or for patients compliant to therapy (ie, taking blinded study treatment ≥80% of the time) compared with less compliant patients. Randomization to ticagrelor was a strong independent inverse predictor of definite stent thrombosis (HR, 0.65; 95% CI, 0.48-0.88). - - Conclusion— - - Ticagrelor compared with clopidogrel reduces the incidence of stent thrombosis in patients with acute coronary syndromes, with consistent benefit across a broad range of patient, stent, and treatment characteristics. - - Clinical Trial Registration— - - URL: http://www.clinicaltrials.gov. Unique identifier: NCT00391872. 
650 4 |a blood platelets 
650 4 |a stents 
650 4 |a thrombosis 
700 1 |a Harrington, Robert A.  |e VerfasserIn  |4 aut 
700 1 |a Emanuelsson, Håkan  |e VerfasserIn  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Mahaffey, Kenneth W.  |e VerfasserIn  |4 aut 
700 1 |a Meier, Bernhard  |e VerfasserIn  |4 aut 
700 1 |a Storey, Robert F.  |e VerfasserIn  |4 aut 
700 1 |a Wojdyla, Daniel M.  |e VerfasserIn  |4 aut 
700 1 |a Lewis, Basil S.  |e VerfasserIn  |4 aut 
700 1 |a Maurer, Gerald  |e VerfasserIn  |4 aut 
700 1 |a Wallentin, Lars  |e VerfasserIn  |4 aut 
700 1 |a James, Stefan K.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Circulation  |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950  |g 128(2013), 10, Seite 1055-1065  |h Online-Ressource  |w (DE-627)265784670  |w (DE-600)1466401-X  |w (DE-576)074891189  |x 1524-4539  |7 nnas  |a Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes 
773 1 8 |g volume:128  |g year:2013  |g number:10  |g month:9$  |g pages:1055-1065  |g extent:11  |a Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes 
856 4 0 |u https://doi.org/10.1161/CIRCULATIONAHA.113.002589  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.113.002589  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220215 
993 |a Article 
994 |a 2013 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |d 50000  |e 910000PK108916618  |e 910100PK108916618  |e 50000PK108916618  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4 
999 |a KXP-PPN1789622859  |e 4059962821 
BIB |a Y 
SER |a newspaper 
JSO |a {"relHost":[{"part":{"pages":"1055-1065","extent":"11","year":"2013","volume":"128","issue":"10","text":"128(2013), 10, Seite 1055-1065"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedDisp":"1950-","dateIssuedKey":"1950","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]"}],"type":{"bibl":"newspaper","media":"Online-Ressource"},"note":["Gesehen am 10.10.2025"],"disp":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromesCirculation","id":{"eki":["265784670"],"zdb":["1466401-X"],"issn":["1524-4539"]},"title":[{"title_sort":"Circulation","title":"Circulation","subtitle":"an official journal of the American Heart Association"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"American Heart Association"}],"pubHistory":["1.1950 -"],"recId":"265784670"}],"person":[{"role":"aut","display":"Steg, P. Gabriel","given":"P. Gabriel","roleDisplay":"VerfasserIn","family":"Steg"},{"given":"Robert A.","display":"Harrington, Robert A.","role":"aut","family":"Harrington","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Emanuelsson","given":"Håkan","display":"Emanuelsson, Håkan","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Katus","given":"Hugo","display":"Katus, Hugo","role":"aut"},{"given":"Kenneth W.","display":"Mahaffey, Kenneth W.","role":"aut","family":"Mahaffey","roleDisplay":"VerfasserIn"},{"family":"Meier","roleDisplay":"VerfasserIn","given":"Bernhard","role":"aut","display":"Meier, Bernhard"},{"roleDisplay":"VerfasserIn","family":"Storey","given":"Robert F.","display":"Storey, Robert F.","role":"aut"},{"display":"Wojdyla, Daniel M.","role":"aut","given":"Daniel M.","roleDisplay":"VerfasserIn","family":"Wojdyla"},{"given":"Basil S.","display":"Lewis, Basil S.","role":"aut","roleDisplay":"VerfasserIn","family":"Lewis"},{"display":"Maurer, Gerald","role":"aut","given":"Gerald","roleDisplay":"VerfasserIn","family":"Maurer"},{"roleDisplay":"VerfasserIn","family":"Wallentin","display":"Wallentin, Lars","role":"aut","given":"Lars"},{"family":"James","roleDisplay":"VerfasserIn","display":"James, Stefan K.","role":"aut","given":"Stefan K."}],"name":{"displayForm":["P. Gabriel Steg, Robert A. Harrington, Håkan Emanuelsson, Hugo A. Katus, Kenneth W. Mahaffey, Bernhard Meier, Robert F. Storey, Daniel M. Wojdyla, Basil S. Lewis, Gerald Maurer, Lars Wallentin, Stefan K. James for the PLATO Study Group"]},"physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"2013"}],"type":{"media":"Online-Ressource","bibl":"article-newspaper"},"language":["eng"],"note":["Gesehen am 15.02.2022"],"recId":"1789622859","id":{"doi":["10.1161/CIRCULATIONAHA.113.002589"],"eki":["1789622859"]},"title":[{"title_sort":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes","title":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes"}]} 
SRT |a STEGPGABRISTENTTHROM2013